Serum and tissue profiling in bladder cancer combining protein and tissue arrays

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 164-173

  Orenes Piñero, Esteban ^a   Barderas, Rodrigo ^a,b   Rico, Daniel ^a   Casal, J Ignacio ^a,b   Gonzalez Pisano, David ^a   Navajo, Jose ^c   Algaba, Ferran ^d   Piulats, Josep Maria ^e   Sanchez Carbayo, Marta ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d FUNDACIÓ PUIGVERT   (Spain)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Autoantibodies; Bladder cancer; Clusterin; Dynamin; Protein array

Indexed keywords

CLUSTERIN; DYNAMIN;

ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CLUSTERIN; DISEASE PROGRESSION; DYNAMINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 73649141727     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900273u     Document Type: Article

References (52)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics. CA Cancer J. Clin. 2008, 58, 71-96.
2. Kirkali, Z.; Chan, T.; Manoharan, M.; Algaba, F.; Busch, C.; Cheng, L.; Kiemeney, L.; Kriegmair, M.; Montironi, R.; Murphy, W. M.; Sesterhenn, I. A.; Tachibana, M.; Weider, J. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005, 66, 4-34.
3. Sanchez-Carbayo, M.; Cordon-Cardo, C. Molecular alterations associated with bladder cancer progression. Semin. Oncol. 2007, 34, 75-84.
4. Zhang, J. Y.; Casiano, C. A.; Peng, X. X.; Koziol, J. A.; Chan, E. K.; Tan, E. M. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol. Biomarkers Prev. 2003, 12, 136-143.
5. Bouwman, K.; Qiu, J.; Zhou, H.; Schotanus, M.; Mangold, L. A.; Vogt, R.; Erlandson, E.; Trenkle, J.; Partin, A. W.; Misek, D.; Omenn, G. S.; Haab, B. B.; Hanash, S. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics 2003, 3, 2200-2207.
6. Cekaite, L.; Haug, O.; Myklebost, O.; Aldrin, M.; ∅stenstad, B.; Holden, M.; Frigessi, A.; Hovig, E.; Sioud, M. Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method. Proteomics 2004, 4, 2572-2582.
7. Hong, S. H.; Misek, D. E.; Wang, H.; Puravs, E.; Giordano, T. J.; Greenson, J. K.; Brenner, D. E.; Simeone, D. M.; Logsdon, C. D.; Hanash, S. M. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res. 2004, 64, 5504-5510.
8. Zhang, J. Y. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Cancer Detect. Prev. 2004, 28, 114-118.
9. Qiu, J.; Madoz-Gurpide, J.; Misek, D. E.; Kuick, R.; Brenner, D. E.; Michailidis, G.; Haab, B. B.; Omenn, G. S.; Hanash, S. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J. Proteome Res. 2004, 3, 261-267.
10. Sreekumar, A.; Laxman, B.; Rhodes, D. R.; Bhagavathula, S.; Harwood, J.; Giacherio, D.; Ghosh, D.; Sanda, M. G.; Rubin, M. A.; Chinnaiyan, A. M. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J. Natl. Cancer Inst. 2004, 96, 834-843.
11. Mian, S.; Ugurel, S.; Parkinson, E.; Schlenzka, I.; Dryden, I.; Lancashire, L.; Ball, G.; Creaser, C.; Rees, R.; Schadendorf, D. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. J. Clin. Oncol. 2005, 23, 5088-5093.
12. Wang, X.; Yu, J.; Sreekumar, A.; Varambally, S.; Shen, R.; Giacherio, D.; Mehra, R.; Montie, J. E.; Pienta, K. J.; Sanda, M. G.; Kantoff, P. W.; Rubin, M. A.; Wei, J. T.; Ghosh, D.; Chinnaiyan, A. M. Autoantibody signatures in prostate cancer. N. Engl. J. Med. 2005, 353, 1224-1235.
13. Chatterjee, M.; Mohapatra, S.; Ionan, A.; Bawa, G.; Ali-Fehmi, R.; Wang, X.; Nowak, J.; Ye, B.; Nahhas, F. A.; Lu, K.; Witkin, S. S.; Fishman, D.; Munkarah, A.; Morris, R.; Levin, N. K.; Shirley, N. N.; Tromp, G.; Abrams, J.; Draghici, S.; Tainsky, M. A. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res. 2006, 66, 1181-1190.
14. Qin, S.; Qiu, W.; Ehrlich, J. R.; Ferdinand, A. S.; Richie, J. P.; O'leary, M. P.; Lee, M. L.; Liu, B. C. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling. Proteomics 2006, 6, 3199-3209.
15. Casiano, C. A.; Mediavilla-Varela, M.; Tan, E. M. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol. Cell. Proteomics 2006, 5, 1745-1759.
16. Ehrlich, J. R.; Qin, S.; Liu, B. C. The 'reverse capture' autoantibody microarray: a native antigen-based platform for autoantibody profiling. Nat. Protoc. 2006, 1, 452-460.
17. Kattah, M. G.; Alemi, G. R.; Thibault, D. L.; Balboni, I.; Utz, P. J. A new two-color Fab labeling method for autoantigen protein microarrays. Nat. Methods 2006, 3, 745-751.
18. Caron, M.; Choquet-Kastylevsky, G.; Joubert-Caron, R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mol. Cell. Proteomics 2007, 6, 1115-1122.
19. Nesslinger, N. J.; Sahota, R. A.; Stone, B.; Johnson, K.; Chima, N.; King, C.; Rasmussen, D.; Bishop, D.; Rennie, P. S.; Gleave, M.; Blood, P.; Pai, H.; Ludgate, C.; Nelson, B. H. Standard treatments induce antigen-specific immune responses in prostate cancer. Clin. Cancer Res. 2007, 13, 1493-1502.
20. Chen, G.; Wang, X.; Yu, J.; Varambally, S.; Yu, J.; Thomas, D. G.; Lin, M. Y.; Vishnu, P.; Wang, Z.; Wang, R.; Fielhauer, J.; Ghosh, D.; Giordano, T. J.; Giacherio, D.; Chang, A. C.; Orringer, M. B.; El-Hefnawy, T.; Bigbee, W. L.; Beer, D. G.; Chinnaiyan, A. M. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res. 2007, 67, 3461-3467.
21. Hudson, M. E.; Pozdnyakova, I.; Haines, K.; Mor, G.; Snyder, M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 17494-17499.
22. Lin, H. S.; Talwar, H. S.; Tarca, A. L.; Ionan, A.; Chatterjee, M.; Ye, B.; Wojciechowski, J.; Mohapatra, S.; Basson, M. D.; Yoo, G. H.; Peshek, B.; Lonardo, F.; Pan, C. J.; Folbe, A. J.; Draghici, S.; Abrams, J.; Tainsky, M. A. Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 2396-2405.
23. Madoz-G úrpide, J.; Kuick, R.; Wang, H.; Misek, D. E.; Hanash, S. M. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol. Cell. Proteomics 2008, 7, 268-281.
24. Taylor, B. S.; Pal, M.; Yu, J.; Laxman, B.; Kalyana-Sundaram, S.; Zhao, R.; Menon, A.; Wei, J. T.; Nesvizhskii, A. I.; Ghosh, D.; Omenn, G. S.; Lubman, D. M.; Chinnaiyan, A. M.; Sreekumar, A. Humoral response profiling reveals pathways to prostate cancer progression. Mol. Cell. Proteomics 2008, 7, 600-611.
25. Li, L.; Chen, S. H.; Yu, C. H.; Li, Y. M.; Wang, S. Q. Identification of hepatocellular-carcinoma-associated antigens and autoanti-bodies by serological proteome analysis combined with protein microarray. J. Proteome Res. 2008, 7, 611-620.
26. Anderson, K. S.; Ramachandran, N.; Wong, J.; Raphael, J. V.; Hainsworth, E.; Demirkan, G.; Cramer, D.; Aronzon, D.; Hodi, F. S.; Harris, L.; Logvinenko, T.; LaBaer, J. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J. Proteome Res. 2008, 7, 1490-1499.
27. Sanchez-Carbayo, M.; Socci, N. D.; Charytonowicz, E.; Lu, M.; Prystowsky, M.; Childs, G.; Cordon-Cardo, C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res. 2002, 62, 6973-6980.
28. Orenes-Piñ ero, E.; Cortón, M.; González-Peramato, P.; Algaba, F.; Casal, I.; Serrano, A.; Sánchez-Carbayo, M. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J. Proteome Res. 2007, 6, 4440-4448.
29. Dawson-Saunders, B. ; Trapp, R. G. Basic & Clinical Biostatistics, 2nd ed.; Appleton & Lange: Norwalk, CT, 1994.
30. Sanchez-Carbayo, M.; Socci, N. D.; Lozano, J. J.; Haab, B. B.; Cordon-Cardo, C. Profiling bladder cancer using targeted antibody arrays. Am. J. Pathol. 2006, 168, 93-103.
31. Burchill, S. A.; Bradbury, M. F.; Pittman, K.; Southgate, J.; Smith, B.; Selby, P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br. J. Cancer 1995, 71, 278-281.
32. Gazzaniga, P. M.; Gandini, O.; Giuliani, L.; Magnanti, M.; Gradilone, A.; Silvestri, I.; Gianni, W.; Gallucci, M.; Frati, L.; Aglianò, A. M. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin. Cancer Res. 2001, 7, 577-583.
33. Retz, M.; Lehmann, J.; Röder, C.; Weichert-Jacobsen, K.; Loch, T.; Romahn, E.; Lü hl, C.; Kalthoff, H.; Stöckle, M. Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients. Eur. Urol. 2001, 39, 507-515.
34. Sanchez-Carbayo, M.; Socci, N. D.; Lozano, J. J.; Li, W.; Chary-tonowicz, E.; Belbin, T. J.; Prystowsky, M. B.; Ortiz, A. R.; Childs, G.; Cordon-Cardo, C. Gene discovery in bladder cancer progression using cDNA microarrays. Am. J. Pathol. 2003, 163, 505-516.
35. Yin, H.; Leong, A. S. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am. J. Clin. Pathol. 2004, 121, 679-687.
36. Rosenberg, M. E.; Silkensen, J. Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 1995, 27, 633-645.
37. Miyake, H.; Nelson, C.; Rennie, P. S.; Gleave, M. E. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res. 2000, 60, 2547-2554.
38. Miyake, H.; Hara, I.; Kamidono, S.; Gleave, M. E. Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin. Cancer Res. 2001, 7, 4245-4252.
39. Zhang, H.; Kim, J. K.; Edwards, C. A.; Xu, Z.; Taichman, R.; Wang, C. Y. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 2005, 7, 909-915.
40. Shannan, B.; Seifert, M.; Leskov, K.; Willis, J.; Boothman, D.; Tilgen, W.; Reichrath, J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 2006, 13, 12-19.
41. Andersen, C. L.; Schepeler, T.; Thorsen, K.; Birkenkamp-Demtroder, K.; Mansilla, F.; Aaltonen, L. A.; Laurberg, S.; Orntoft, T. F. Clusterin expression in normal mucosa and colorectal cancer. Mol. Cell. Proteomics 2007, 6, 1039-1048.
42. Shpetner, H. S.; Vallee, R. B. Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules. Cell 1989, 59, 421-432.
43. Valentich, M. A.; Cook, T.; Urrutia, R. Expression of dynamin immunoreactivity in experimental pancreatic tumors induced in rat by mancozeb-nitrosomethylurea. Cancer Lett. 1996, 102, 23-29.
44. Trapani, J. A.; Sutton, V. R.; Thia, K. Y.; Li, Y. Q.; Froelich, C. J.; Jans, D. A.; Sandrin, M. S.; Browne, K. A. A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death. J. Cell Biol. 2003, 160, 223-233.
45. Baldassarre, M.; Pompeo, A.; Beznoussenko, G.; Castaldi, C.; Cortellino, S.; McNiven, M. A.; Luini, A.; Buccione, R. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol. Biol. Cell 2003, 14, 1074-1084.
46. Spinardi, L.; Rietdorf, J.; Nitsch, L.; Bono, M.; Tacchetti, C.; Way, M.; Marchisio, P. C. A dynamic podosome-like structure of epithelial cells. Exp. Cell Res. 2004, 295, 360-374.
47. Ivanov, V. N.; Ronai, Z.; Hei, T. K. Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis. J. Biol. Chem. 2006, 281, 1840-1852.
48. Yang, J. Y.; Zong, C. S.; Xia, W.; Wei, Y.; Ali-Seyed, M.; Li, Z.; Broglio, K.; Berry, D. A.; Hung, M. C. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol. Cell. Biol. 2006, 26, 7269-7282.
49. Hall, J. C.; Casciola-Rosen, L.; Rosen, A. Altered structure of autoantigens during apoptosis. Rheum. Dis. Clin. North Am. 2004, 30, 455-471.
50. Wu, X.; Molinaro, C.; Johnson, N.; Casiano, C. A. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthritis Rheum. 2001, 44, 2642-2652.
51. Lu, M.; Nakamura, R. M.; Dent, E. D.; Zhang, J. Y.; Nielsen, F. C.; Christiansen, J.; Chan, E. K.; Tan, E. M. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am. J. Pathol. 2001, 159, 945-953.
52. Casciola-Rosen, L.; Nagaraju, K.; Plotz, P.; Wang, K.; Levine, S.; Gabrielson, E.; Corse, A.; Rosen, A. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J. Exp. Med. 2005, 201, 591-601.